Summary.-To determine whether vindesine receptors are present in human leukaemic cells, K562 cells (established from chronic myelogenous leukaemia in blastic crisis) were incubated with 3H-vindesine. Binding of 3H-vindesine increased with incubation time and with increase in number of K562 cells. However, when excessive amounts of nonradioactive vindesine were added, the 3H-vindesine was displaced. Binding of 3H-vindesine was only inhibited by vinblastine, vincristine and vindesine. These results suggest that K562 cells have receptors for vindesine and that these receptors are common to vinca alkaloids.
THE TREATMENT of certain types of malignancies with vinca alkaloids reduces the number of tumour cells. The effects of the treatment, however, differ from disease to disease and even from case to case in the same disease. The causes of the difference are not known. Since it has been shown that in hormonal therapy of breast cancer the number of hormone receptors may significantly influence the course of the disease (Knight et al., 1977; McGuire, 1975) , we speculated that the effects of vinca alkaloids might depend on the number of vinca-alkaloid receptors in the tumour cells, or on their affinity to the receptor site. As far as we know, detailed studies have not been performed on viycaalkaloid receptors in human tumour cells, nor on their clinical relevance.
A new vinca-alkaloid derivative, vindesine, is currently under evaluation in clinical cancer chemotherapy (Miller et al., 1980; Stambaugh, 1980; Young, 1980) . The physiological mechanisms by which vinca alkaloids kill cells in vivo and in vitro are not clear. Since vinblastine and vincristine are known to bind to tubulin from brain (Owellen et al., 1972 (Owellen et al., , 1974 or HeLa cells (Marantz et al., 1969) , the major protein subunit of microtubules, with high affinity and specificity, it has been postulated that vinca alkaloids affect the spindle microtubules during metaphase (Palmer et al., 1960; Cutts, 1961) , resulting in abnormal cytokinesis of the cells, which causes multinucleated cells and cell death (Chirife & Studzinski, 1978) . Recently, the interaction between tubulin from a pig brain and vindesine was also described (Owellen et al., 1977 (Gout et al., 1978; Secret et al., 1972) , these were removed by centrifuging x 3 at 600 g for 45 sec and the pellets were used. Studies on the binding of the cultured cells were performed during their log phase of growth (2-3 days after reseeding in liquid culture). After being washed twice with phosphate-buffered saline (pH 7.4) containing 1% bovine serum albumin (PBS c BSA) the cells were suspended at a density between 2 and 8x 106 cells/ml in PBS c BSA. Most measurements of the binding were made at a cell concentration of 4 x 106 cells/ml. Aliquots of 0 3 ml of the cell suspension were delivered into 12 x 105mm glass test tubes (Pyrex and Iwaki Glass, Tokyo) and incubated at 37°C with 0-123 juCi of 3H-vindesine (sp. act. 4.7 Ci/mmol, 5-6 mCi/mg, Radiochemical Centre, Amersham, U.K.) with or without 200-fold unlabelled vindesine (10-5M). The residual binding in the presence of nonradioactive vindesine was assumed to represent nonspecific binding, and the difference between the total binding of 3H-vindesine and this nonspecific binding was taken to be specific binding of vindesine. At the end of the incubation period, 6 ml of cold PBS c BSA was rapidly added to each tube and the cells were washed x 3 with PBS a BSA. The cell pellets were then dissolved with 0-6 ml of Protosol (New England Nuclear, Boston), to which 10 ml of liquid scintillator (ACS II, Radiochemical Centre, Amersham, U.K.) was added. This solution was transferred to liquid scintillation vials, and its radioactivity was counted by a liquid scintillation counter. In order to determine the specificity of vindesine receptor in K562 cells, other unlabelled antileukaemic agents such as vincristine, vinblastine, cytosine arabinoside, daunorubicin or 6MP-ribose were added with 3H-vindesine.
RESULTS
K562 cells, 1-2 x 106, were incubated at 37°C with 0-123 ,uCi of 3H-vindesine for various lengths of time (Fig. 1) . Binding of 3H-vindesine increased with incubation time, and reached a plateau at 4-6 h. When 200-fold excess of nonradioactive vindesine was added as a chaser after 2 h incubation, the 3H-vindesine was displaced. 3H-Vindesine binding increased as the number of cells increased (Fig. 2) .
In Fig. 3 , the specificity of the vincaalkaloid receptor binding was investigated by testing the ability of the various unlabelled agents to compete with 3H-vindesine for vinca-alkaloid binding sites. The binding of 3H-vindesine was competitively blocked by the addition of various amounts of unlabelled vindesine, vincristine or vinblastine. The above 3 agents displayed virtually the same degree of inhibition. The same concentrations of daunorubicin, cytosine arabinoside and 6MP-ribose, however, did not block the binding of 3H-vindesine (Fig. 4) .
Scatchard analysis was performed to determine the number of vindesine receptors in K562, MOLT-4 and HL-60 cells, and normal blood lymphocytes. 4-2 x 10-7M, 4-8 x 10-7M, 4.5 x 10-7M and 3.3 x 10-7M, respectively (Fig. 5) .
DISCUSSION
The results of this study suggested that K562 cells have receptors for vindesine, since the binding of 3H-vindesine to K562 cells increased with incubation time (Fig.  1) and with increase in the number of K562 cells (Fig. 2) , and because this binding was reversible (Fig. 1) . The binding of 3H-vindesine was inhibited by vinblastine and vincristine to almost the same degree with vindesine ( Fig. 3) and was not inhibited by agents other than vinca alkaloids (Fig. 4) , suggesting that K562 cells have common receptors for these vinca alkaloids.
Vinca alkaloids are cell-cycle-specific agents. According to previous studies on vinblastine and vincristine, they bind specifically to the protein tubulin from pig or rat brain, a key component of microtubules (Marantz et al., 1969; al. , 1972, 1974) . Indeed, it was demonstrated that tubulin is a receptor for vinblastine and vincristine (Wilson et al., 1974) . Since the binding of vinblastine to tubulin from pig brain was displaced by vindesine according to Owellen et al. (1977) , and the present data (Fig. 3 The authors wish to thank Dr T. Tsushima for helpful discussions and expert advice on the experimental procedures. This work was partially supported by a research grant from the Japanese Ministry of Education.
